For Doctors in a Hurry
- Clinicians often struggle to identify the genetic etiology of X-linked intellectual disability in families with variable clinical presentations.
- The researchers analyzed three family members with a confirmed duplication of the Xq28 region involving six specific genes.
- Two male siblings exhibited profound intellectual disability, epilepsy, and spastic cerebral palsy, while their mother showed milder symptoms.
- The authors conclude that the duplication of multiple dosage-sensitive genes explains the multisystem involvement and observed phenotypic variability.
- Physicians should consider Xq28 duplication in the differential diagnosis for patients presenting with intellectual disability and additional neurological impairment.
Navigating the Clinical Complexity of X-Linked Intellectual Disability
X-linked intellectual disability represents a significant diagnostic challenge for clinicians, accounting for approximately 16% of intellectual disability cases in males [1]. Among these, copy number variations (structural changes where sections of the genome are repeated or deleted) involving the MECP2 gene at the Xq28 locus are increasingly recognized as a primary cause of severe neurodevelopmental delay, epilepsy, and recurrent infections [2, 3]. While the loss of MECP2 function typically results in Rett syndrome, duplications of this dosage-sensitive region produce a distinct but highly variable clinical profile that often overlaps with other syndromic presentations [4, 5]. Recent advances in genomic sequencing and multi-omic analysis (the integrated study of the genome, transcriptome, and proteome) have begun to clarify how these genetic rearrangements disrupt synaptic activity and neuronal function [6, 7]. A new study now offers fresh insights into the phenotypic diversity of Xq28 duplications by examining a multi-generational family with complex multisystem involvement.
Genomic Architecture of the Xq28 Duplication
The study identified a confirmed duplication of the Xq28 region as the underlying cause of the multisystemic disability observed in the family, involving a specific cluster of six distinct genes: SLC6A8, L1CAM, MECP2, TKTL1, FLNA, and GDI1. Clinicians should recognize that Xq28 duplication represents the most common X-linked copy number variation associated with intellectual disability. The identification of this specific six-gene cluster provides a clear genetic etiology for the diverse symptoms presented by the patients, ranging from neurological deficits to cutaneous manifestations. For example, the inclusion of L1CAM (a gene involved in neuronal cell adhesion) and MECP2 (a critical regulator of gene expression in the brain) explains the profound impact on neurodevelopment and motor function.
The clinical complexity observed in these patients stems from the presence of multiple dosage-sensitive genes within the duplicated segment. Dosage sensitivity refers to a genetic state where the number of gene copies directly affects the volume of protein produced and the resulting clinical traits. The researchers concluded that the duplication of these dosage-sensitive genes likely explains the multisystem involvement seen in the affected individuals. Because these genes regulate critical pathways in neurological and physical development, an increase in their expression levels disrupts homeostatic balance (the stable internal equilibrium required for normal cellular function). This mechanism accounts for the severe phenotypes in males and the marked phenotypic variability observed between male and female family members, as the latter are influenced by varying patterns of X-chromosome inactivation.
Divergent Phenotypes in Male and Female Family Members
The clinical presentation of X-linked intellectual disability within this single family demonstrates a stark contrast between sexes, driven by the biological mechanisms of inheritance. In females, the clinical expression of the disorder is notably variable, a phenomenon that depends on patterns of X-chromosome inactivation. This process involves the random silencing of one of the two copies of the X chromosome in female cells, which can result in a mosaic of healthy and affected cells. Consequently, the mother of the affected siblings in this study exhibited a significantly milder phenotype, characterized by mild intellectual disability and skin manifestations. This variability highlights the challenge of identifying female carriers who may only present with subtle neurological or cutaneous signs, potentially leading to underdiagnosis in the absence of affected male relatives.
In contrast, the two male siblings in the family presented with severe phenotypes because they lack a second, compensatory X chromosome. Their clinical profiles included profound intellectual disability and severe speech impairment, alongside significant behavioral issues and distinct facial dysmorphism. The neurological burden was further compounded by the presence of spastic cerebral palsy and epilepsy, conditions that require intensive multidisciplinary management. Beyond these neurological deficits, the researchers documented cutaneous abnormalities in the brothers, mirroring the skin manifestations seen in their mother but within a more debilitating multisystemic context. The duplication of dosage-sensitive genes within the Xq28 region explains this marked phenotypic variability between male and female family members.
The broader family history suggests that these findings are not isolated incidents but part of a larger hereditary pattern. Records indicated the existence of additional affected male relatives who displayed similar or even more severe clinical presentations than the siblings described in the study. This pedigree reinforces the high penetrance (the probability that a specific genetic variant will result in a clinical phenotype) of the Xq28 duplication in males and underscores the importance of thorough family histories when clinicians encounter patients with unexplained intellectual disability accompanied by complex neurological and physical impairments.
Clinical Implications for Differential Diagnosis
The identification of Xq28 duplications carries significant weight in the clinical evaluation of neurodevelopmental disorders, as pathogenic variants in X-chromosomal genes account for approximately 16% of intellectual disability cases in males. Given this prevalence, clinicians should maintain a high index of suspicion for X-linked inheritance when assessing male patients with cognitive deficits. The researchers emphasize that Xq28 duplication represents the most common X-linked copy number variation associated with intellectual disability. Consequently, this genetic anomaly should be a primary consideration in the differential diagnosis for families exhibiting patterns of X-linked intellectual disability, particularly when the clinical picture is complicated by multisystemic involvement.
The study suggests that specific clinical 'red flags' can help physicians distinguish Xq28 duplications from other forms of X-linked intellectual disability. Clinicians should prioritize genetic testing for this duplication when intellectual disability is accompanied by additional neurological impairment, such as epilepsy or spastic cerebral palsy, and cutaneous abnormalities. The multisystemic nature of the disorder is driven by the duplication of multiple dosage-sensitive genes, including SLC6A8, L1CAM, MECP2, TKTL1, FLNA, and GDI1. Because these genes are critical for diverse physiological processes, their overexpression leads to the profound neurological and physical phenotypes observed in affected males.
For the practicing physician, these findings underscore the necessity of a detailed family history and a low threshold for genomic analysis in complex cases. Because pathogenic variants in X-chromosomal genes cause nearly one-sixth of male intellectual disability, identifying the specific Xq28 duplication allows for more precise prognostic counseling. Furthermore, recognizing the variable and often subtle clinical expression in female carriers, such as mild intellectual disability or minor skin manifestations, is essential for identifying at-risk families. Accurate diagnosis through the identification of these six duplicated genes facilitates better management of the associated epilepsy and spasticity while providing families with essential information regarding recurrence risks and reproductive options.
References
1. Mefford HC, Batshaw ML, Hoffman EP. Genomics, Intellectual Disability, and Autism. New England Journal of Medicine. 2012. doi:10.1056/nejmra1114194
2. Pascual-Alonso A, Xiol C, Smirnov D, Kopajtich R, Prokisch H, Armstrong J. Multi‐omics in MECP2 duplication syndrome patients and carriers. European Journal of Neuroscience. 2024. doi:10.1111/ejn.16389
3. Akaba Y, Takahashi S. MECP2 duplication syndrome: Recent advances in pathophysiology and therapeutic perspectives.. Brain & development (Tokyo. 1979). 2025. doi:10.1016/j.braindev.2025.104371
4. Tascini G, Dell’Isola GB, Mencaroni E, Cara GD, Striano P, Verrotti A. Sleep Disorders in Rett Syndrome and Rett-Related Disorders: A Narrative Review. Frontiers in Neurology. 2022. doi:10.3389/fneur.2022.817195
5. Vega-Hanna L, Casas-Alba D, Balsells S, et al. MECP2 Duplication Syndrome: AI-Based Diagnosis, Severity Scale Development and Correlation with Clinical and Molecular Variables. Diagnostics. 2024. doi:10.3390/diagnostics15010010
6. Jiang C, Lin L, Long S, et al. Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications. Signal Transduction and Targeted Therapy. 2022. doi:10.1038/s41392-022-01081-0
7. Lunke S, Bouffler SE, Patel C, et al. Integrated multi-omics for rapid rare disease diagnosis on a national scale. Nature Medicine. 2023. doi:10.1038/s41591-023-02401-9
